2-氧代-2,5,6,7-四氢-1H-环戊二烯并[b]吡啶-3-甲腈 | 108106-97-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-氧代-2,5,6,7-四氢-1H-环戊二烯并[b]吡啶-3-甲腈
• 英文名称: 2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carbonitrile
• 英文别名: 2-oxo-1,5,6,7-tetrahydrocyclopenta[b]pyridine-3-carbonitrile
• CAS: 108106-97-4
• 化学式: C₉H₈N₂O
• mdl: MFCD03851982
• 分子量: 160.175
• InChiKey: CNZRRQHIZFDOSX-UHFFFAOYSA-N

物化性质

• 沸点：
  478.2±28.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  52.9
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933790090

反应信息

• 作为反应物：
  描述：

  2-氧代-2,5,6,7-四氢-1H-环戊二烯并[b]吡啶-3-甲腈 在 镍 盐酸 、 manganese(IV) oxide 、 正丁基锂 、 四甲基乙二胺 、 硫酸 、 苄基三乙基氯化铵 、 氢气 、 硝酸 、 三乙胺 、 三氯氧磷 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 甲苯 、 乙腈 为溶剂， 80.0 ℃ 、202.65 kPa 条件下， 反应 172.0h， 生成 3-Amino-4-(3-methylbenzoyl)-1,5,6,7-tetrahydrocyclopenta[b]pyridin-2-one
  参考文献：
  名称：

  4-Benzyl and 4-Benzoyl-3-dimethylaminopyridin-2(1H)-ones:  In Vitro Evaluation of New C-3-Amino-Substituted and C-5,6-Alkyl-Substituted Analogues against Clinically Important HIV Mutant Strains

  摘要：

  In a program to optimize the anti-HIV activity of the 4-benzyl and 4-benzoyl-3-dimethylaminopyridinones 9 and 10, lead compounds in a new class of highly potent non-nucleoside type inhibitors of HIV-1 reverse transcriptase, modification of the alkyl substitutents at the C-5 and C-6 positions on the pyridinone ring and of the substitutents on the C-3 amino group has been studied. Of the 17 new 5/6-modified analogues prepared, compounds 31b and 32b substituted at C-5 by an extended nonpolar chain containing an ether function and a C-6 methyl group and compound 35 bearing a C-5 ethyl/C-6 hydroxymethyl substituent pattern were selected on the basis of their in vitro activity against wild-type HIV and the three principle mutant strains, K103N, Y181C, and Y188L. When tested further, it was shown that these molecules, and in particular compound 35, are globally more active than 9, 10, and efavirenz against an additional eight single [L100I, K101E, V106A, E138K, V179E, G190A/S, and F227C] and four double HIV mutant strains [L1001 + K103N, K101E + K103N, K103N + Y181C, and F227L + V106A] which are clinically relevant. Concerning modulation of the N-3 substituent, 36 new analogues were prepared. Of these, the N-methyl-N-(2-methoxyethyl)-substituted compounds 40, 42, and 62, as well as the doubly modified compounds 77a and 77b, were selected from the initial screen and were subsequently shown to be active at sub-micromolar concentrations (IC50'S) against all the other mutant strains except K103N + Y181C and F227L + V106A. Two possible, but distinct, modes of binding of these analogues in RT were suggested from molecular modeling studies. The preferred mode of binding for compound 62, corresponding to the predicted "orientation 1", was revealed in the X-ray crystal structure of the compound 62-RT complex.

  DOI：

  10.1021/jm0408621
• 作为产物：
  描述：

  环戊酮 在 sodium 、 哌啶乙酸盐 作用下， 以 乙醚 、 水 为溶剂， 反应 8.0h， 生成 2-氧代-2,5,6,7-四氢-1H-环戊二烯并[b]吡啶-3-甲腈
  参考文献：
  名称：

  通过 TCCA 催化的缩合和 Nenitzescu 反应组装的基于 5-羟基吲哚的 EZH2 抑制剂

  摘要：

  5-羟基吲哚衍生物具有多种已证实的生物活性。在此，我们使用 5-羟基吲哚作为合成起点，在组合过程中进行结构改变，以合成 22 种具有 EZH2 抑制剂药效团的不同化合物。筛选了一系列 5-羟基吲哚衍生化合物对 K562 细胞的抑制活性。根据分子建模和体外生物活性测定，初步总结了构效关系。化合物 L-04 改善了 H3K27Me3 减少和抗增殖参数（IC50 = 52.6 μM）。这些发现表明，化合物 L-04 值得考虑作为设计更有效 EZH2 抑制剂的先导化合物。在化合物制备过程中，我们发现三氯异氰尿酸 (TCCA) 是一种新型催化剂，具有缩合促进作用。为了深入了解反应，使用原位反应红外技术来确认反应性。在TCCA的存在下，不同的胺与β-二酮或β-酮酯以高产率缩合，在短时间内（10~20分钟）得到相应的产物，这显示了一些优势并提供了替代的缩合策略。

  DOI：

  10.3390/molecules25092059

文献信息

• Design, synthesis and biological activities of pyrrole-3-carboxamide derivatives as EZH2 (enhancer of zeste homologue 2) inhibitors and anticancer agents
  作者：Qifan Zhou、Lina Jia、Fangyu Du、Xiaoyu Dong、Wanyu Sun、Lihui Wang、Guoliang Chen

  DOI：10.1039/c9nj04713a

  日期：——

  Zeste enhancer homolog 2 (EZH2) is highly expressed in various malignant tumors, which could silence tumor suppressor genes via trimethylation of H3K27. Herein was first reported a novel series of pyrrole-3-carboxamide derivatives carrying a pyridone fragment as EZH2 inhibitors. By combining computational modeling, in vitro cellular assays and further rational structure–activity relationship exploration

  Zeste增强子同源物2（EZH2）在各种恶性肿瘤中高表达，可以通过H3K27的三甲基化沉默沉默抑癌基因。本文首先报道了一系列带有吡啶酮片段作为EZH2抑制剂的吡咯-3-羧酰胺衍生物。通过将计算模型，体外细胞分析以及进一步的合理的构效关系探索和优化相结合，化合物DM-01对EZH2具有强大的抑制作用。在蛋白质印迹试验中，发现DM-01具有降低K562细胞中细胞H3K27me3水平的显着能力。同时，我们的数据显示，敲低A549细胞中的EZH2导致细胞对DM-01的敏感性降低在50和100μM下 DM-01还可以以剂量依赖的方式增加DIRAS3的转录表达，这是EZH2下游的一种抑癌剂，表明它有必要进一步研究作为先导化合物。
• [EN] COMPOUNDS AND USE THEREOF IN THE EXPANSION OF STEM CELLS AND/OR PROGENITOR CELLS<br/>[FR] COMPOSÉS ET LEUR UTILISATION DANS L'EXPANSION DE CELLULES SOUCHES ET/OU DE CELLULES PROGÉNITRICES
  申请人：UNIV MONTREAL

  公开号：WO2019087129A1

  公开（公告）日：2019-05-09

  The invention relates to compounds of formula I and pharmaceutical compositions containing them. Also, the invention relates to methods for expanding stem cells and/or progenitor cells and methods for treating a hematopoietic disorder/malignancy, and autoimmune disease and/or an inherited immunodeficient disease (I).

  该发明涉及公式I的化合物和含有这些化合物的药物组合物。此外，该发明涉及扩展干细胞和/或祖细胞的方法，以及治疗造血障碍/恶性肿瘤、自身免疫疾病和/或遗传性免疫缺陷疾病的方法。
• Zinc (II)-Mediated Selective O-Benzylation of 2-Oxo-1,2-Dihydropyridines Systems
  作者：Qifan Zhou、Fangyu Du、Xinjie Liang、Wenqiang Liu、Ting Fang、Guoliang Chen

  DOI：10.3390/molecules23071784

  日期：——

  system of ZnO, ZnCl2 and N,N-diisopropylethylamine (DIEA), that is highly effective for selective O-benzylation of 2-oxo-1,2-dihydropyridines using abundant substituted benzyl halides and related substituted 2-oxo-1,2-dihydropyridines compounds. This process allows access to a variety of O-benzyl products under mild reaction conditions, which are important synthetic intermediates in the protection of

  2-oxo-1,2-dihydropyridines 的选择性 O-苄基化在天然产物和生物活性分子的有机合成中起着关键作用。在此，我们报告了一种新型的 ZnO、ZnCl2 和 N,N-二异丙基乙胺 (DIEA) 的三元体系，该体系对于使用大量取代的苄基卤化物和相关取代的 2- 2-氧代-1,2-二氢吡啶的选择性 O-苄基化非常有效。氧代-1,2-二氢吡啶类化合物。该过程允许在温和的反应条件下获得各种 O-苄基产物，它们是保护官能团的重要合成中间体，代表了一种开发 2-oxo-1,2 的 O-苄基化的新方法-二氢吡啶。
• Synthesis and Solid-State Structures of Alkyl-Substituted 3-Cyano-2-pyridones
  作者：Christian B. Fischer、Kurt Polborn、Harald Steininger、Hendrik Zipse

  DOI：10.1515/znb-2004-1008

  日期：2004.10.1

  A series of 3-cyano-pyridones carrying a variety of alkyl substituents at C-5 and C-6 has been synthesized and their solid-state structures have been studied. Hydrogen bonding interactions between individual pyridone molecules lead either to the formation of symmetric dimers of the R² ₂ (8) type or to helical chains of the C(4) type. Based on known and calculated structures for the 2-pyridone parent system, the solid-state structures can be divided in two groups representing cases with little external influence on the hydrogen bonding array (group A) and those with a larger external influence (group B).

  一系列在C-5和C-6位置带有各种烷基取代基的3-氰基吡啶酮已经合成，并研究了它们的固态结构。单个吡啶酮分子之间的氢键相互作用会导致形成对称二聚体R²₂（8）型或螺旋链C（4）型。基于已知和计算得到的2-吡啶酮母体系统的结构，固态结构可以分为两组，代表对氢键阵列影响较小的情况（A组）和对氢键阵列有较大外部影响的情况（B组）。
• Synthesis and Neurotropic Activity of Novel Condensed Cyclopentanopyrido[3',2':4,5]-Thieno[3,2-D]Pyrimidine Derivatives
  作者：V. V. Dabaeva、M. R. Bagdasaryan、E. G. Paronikyan、Sh. Sh. Dashyan、R. G. Paronikyan、I. M. Nazaryan、A. G. Akopyan

  DOI：10.1007/s11094-020-02259-y

  日期：2020.10

  point to develop an accessible synthesis of condensed cyclopentanopyrido[3',2':4,5]thieno[3,2-d]pyrimidine derivatives. The neurotropic activity of these compounds was studied, and a number of them showed anticonvulsant activity as antagonism to corasol. Compound II, like diazepam, had anti-anxiety and activating effects, while the other compounds had sedative activity.

  2-Oxo-2,5,6,7-tetrahydro-3-cyano-1H-cyclopenta[b]pyridine 被用作开发稠合环戊基吡啶并 [3',2':4,5] 的可接近合成的起点噻吩并[3,2-d]嘧啶衍生物。研究了这些化合物的神经营养活性，其中一些化合物显示出抗惊厥活性作为对 corasol 的拮抗作用。化合物II与地西泮一样，具有抗焦虑和活化作用，而其他化合物具有镇静作用。